Clinical diagnosis of COPD for at least 1 year before the screening visit
Aged 40 years and older
An indication for triple therapy according to the treating physician (following the GOLD guideline 2021(2)). Could be step-up from dual therapy or currently receiving triple therapy (both MITT and SITT).
Owner of mobile device compatible with e-device app with access to internet (Android or iOS)
Willing to provide written informed consent
Current or ex-smoker
You may not be if
Inability to comply with study procedures or with study treatment
Insufficiently skilled in the Dutch language to be able to read and understand the app. Help by third party (family members) is allowed
Asthma as the predominant disease according to the investigator's opinion, a past history of asthma is allowed
Use of e-health application for COPD in the past six months
Patients with any other therapy that could interfere with the study drugs (according to the investigator's opinion)
Use of nebulized bronchodilators, for example via pari boy
Pregnant or lactating women and all women physiologically capable of becoming pregnant unless they have highly effective contraceptive
Patients mentally or legally incapacitated, or patients accommodated in an establishment as a result of an official or judicial order
Patients without the capability to complete the questionnaires
Clareo Health | Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease
